Vertex Pharmaceuticals · Cash & Short-Term Investments

Latest reported$6.61Bperiod endingDec 31, 2025

VRTX FY Cash & Short-Term Investments ($4.40M → $6.61B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

VRTX cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	6,611,100,000
Dec 31, 2024	6,115,900,000
Dec 31, 2023	11,218,300,000
Dec 31, 2022	10,778,500,000
Dec 31, 2021	7,524,900,000
Dec 31, 2020	6,658,900,000
Dec 31, 2019	3,808,294,000
Dec 31, 2018	3,168,242,000
Dec 31, 2017	2,088,666,000
Dec 31, 2016	1,434,557,000
Dec 31, 2015	1,042,462,000
Dec 31, 2014	1,387,106,000
Dec 31, 2013	1,465,076,000
Dec 31, 2012	1,321,215,000
Dec 31, 2011	968,922,000
Dec 31, 2010	1,031,411,000
Dec 31, 2009	1,284,913,000
Dec 31, 2008	832,101,000
Dec 31, 2007	460,871,000
Dec 31, 2006	704,626,000
Dec 31, 2005	361,157,000
Dec 31, 2004	386,246,000
Dec 31, 2003	583,164,000
Dec 31, 2002	634,984,000
Dec 31, 2001	743,202,000
Dec 31, 2000	459,921,000
Dec 31, 1999	187,802,000
Dec 31, 1998	24,200,000
Dec 31, 1997	71,500,000
Dec 31, 1996	34,900,000
Dec 31, 1995	28,400,000
Dec 31, 1994	71,600,000
Dec 31, 1993	28,600,000
Dec 31, 1992	11,600,000
Dec 31, 1991	27,600,000
Dec 31, 1990	4,400,000